Prime Time+: Engineering a Multi-Pathway Approach to Healthy Aging
Many of the most-studied interventions associated with healthy aging — caloric restriction, intermittent fasting, structured exercise, hormetic stress like cold and heat exposure — converge on several interconnected biological pathways. They support autophagy. They support the body's own reparative stem cell activity. They strengthen mitochondrial resilience. No single pill replicates any of those interventions outright. But a formula can be built, deliberately, around that same convergent biology. That's the question we actually started from: not "what longevity ingredients can we put into one formula," but which biological systems become increasingly important as we age, and how a complementary formula could be built around them. Prime Time+ is the answer we arrived at — three interconnected pathways, plus a fourth component built solely to make sure the first three are actually absorbed.
What follows is the actual reasoning — pathway by pathway, ingredient by ingredient — including where the evidence is strong, where it's still early, and where a finished formula's evidence standard differs from what's been shown for an individual active studied on its own. This is written for the clinicians and practitioners who recommend this formula to patients, not as marketing copy. The specific trials referenced below — for spermidine, for alpha-ketoglutarate, and for StemEnhance® — have each been checked against their original published source rather than cited secondhand from marketing copy; where full-text access to a primary paper was limited, that's flagged explicitly rather than papered over.
The Problem With Single-Mechanism Longevity Products
Walk through the longevity supplement category and the pattern is consistent: a single headline ingredient, one mechanism, one claim. That's a reasonable design when the goal is a simple product story. It's a poor match for how biological aging actually behaves. Autophagy decline, reduced regenerative capacity, and mitochondrial dysfunction rarely occur in isolation in an aging patient — they tend to compound each other. Addressing one axis while ignoring the others leaves most of the underlying biology untouched. Prime Time+ was built on the premise that a formula aimed at systemic healthspan needs to reflect that interconnection.
Pathway 01: Cellular Quality Control and Autophagy
Autophagy is the process by which a cell identifies and clears its own damaged proteins, dysfunctional organelles, and accumulated cellular debris. It's one of the most consistently implicated mechanisms in aging biology, and it's also one of the few longevity pathways with real human trial data behind a specific nutrient: spermidine.
Prime Time+ delivers 10 mg of spermidine as Puremidine®. The strongest human evidence for spermidine and cognitive outcomes comes from a randomized, double-blind trial in 85 nursing-home residents (mean age 83) with mild-to-moderate dementia, published in Wiener klinische Wochenschrift (Pekar et al., 2021). It's worth describing precisely rather than rounding up: the trial compared a higher spermidine dose against a lower dose — not spermidine against a placebo — over three months. Both dose groups improved on the CERAD cognitive battery (high-dose: +6.25 points, p=0.030; low-dose: +4.00 points, p=0.041), with the high-dose group showing the larger gain. In the mild-dementia subgroup specifically, the high-dose group also showed a significant MMSE improvement (+2.23 points, p=0.026); a parallel improvement in phonemic fluency (+1.99 points) did not reach statistical significance (p=0.47). We think it's important to say plainly that this trial was conducted in a dementia population using a dose-comparison design, not in cognitively healthy adults using a placebo-controlled design — a meaningfully different, and more conservative, read than "a clinical trial showed spermidine improves cognition." It's also worth noting, in the interest of giving the full picture, that a larger, placebo-controlled trial in older adults with subjective cognitive decline (the SmartAge trial, published in JAMA Network Open, Wirth et al., 2022) did not find a significant effect on its primary cognitive outcome at a lower spermidine dose — a reminder that this evidence base, while real, is still mixed and dose-dependent.
The mechanistic case for spermidine is on firmer ground. A 2024 Nature Cell Biology paper (Hofer et al.) showed, across yeast, C. elegans, fruit flies, mouse models, and human cell lines — with corroborating data from four human fasting cohorts — that blocking the body's own spermidine synthesis prevents fasting from triggering autophagy or producing its longevity benefits, and that restoring spermidine rescues that effect. That's strong mechanistic support for spermidine as one of the molecular links between fasting biology and a daily nutraceutical, even though it doesn't by itself demonstrate a clinical outcome in humans taking a spermidine supplement. Separately, a Danish research group has published the protocol for POLYCAD (NCT06186102), a randomized, double-blind, placebo-controlled trial of spermidine in elderly patients with coronary artery disease, examining cardiovascular aging and physical performance. The protocol was published in 2025; results are not yet available, and we're citing it here as a trial to watch rather than as evidence in hand.
Three additional actives reinforce autophagy through distinct, non-redundant mechanisms rather than duplicating spermidine's pathway. Fucoidan, standardized to 85% from Undaria pinnatifida (mekabu) sporophyll, is a sulfated polysaccharide studied for promoting autophagic flux through a route separate from spermidine's polyamine-mediated induction, alongside a role in supporting glycocalyx integrity. Luteolin and apigenin contribute a complementary axis: apigenin has been studied for supporting NAD+ homeostasis by modulating CD38, the primary enzyme responsible for NAD+ degradation, while luteolin adds antioxidant and neuro-vascular support. And PureMune™, a yeast-derived beta-1,3/1,6 glucan, engages Dectin-1 receptors on macrophages, dendritic cells, and NK cells — priming innate immune surveillance in a way that's mechanistically linked to autophagy activation rather than acting as an unrelated add-on.
Pathway 02: Regenerative and Stem Cell Mobilization Support
This is the pathway that draws the most scrutiny, and it deserves the most precision. "Stem cell mobilization" refers to a well-characterized, entirely normal physiological process: the release of bone marrow-derived stem and progenitor cells into peripheral circulation, where they contribute to ordinary tissue maintenance and repair. It is worth stating plainly, in the same terms we use with every clinician who asks: Prime Time+ does not contain stem cells, and it does not claim to regenerate tissue through stem cell therapy. What it's formulated to do is support a process the body already runs on its own.
The primary active here is StemEnhance®, a patented water-soluble extract of Aphanizomenon flos-aquae (AFA), a freshwater blue-green algae harvested from Klamath Lake. The core human evidence is a double-blind, randomized crossover study in 12 healthy adults (Jensen et al., Cardiovascular Revascularization Medicine, 2007), which found that consuming 1 gram of the extract produced a transient 18% increase in circulating CD34+ stem cells, peaking at one hour after consumption (p<0.0003) — rising to 25% when three non-compliant participants were excluded from the analysis (p<0.0001). It's worth being precise about the shape of this data: measurements were taken at baseline and at 30, 60, and 120 minutes, so what's been demonstrated is a real, statistically significant, but short-term and small-sample (n=12) mobilization effect — not a sustained elevation tracked over days or weeks. The same paper references earlier related work from the group showing that a larger dose (1.5 grams) of AFA extract produced rapid mobilization of lymphocytes and monocytes within two hours of consumption. We'd recommend one further check — locating that earlier lymphocyte/monocyte paper directly, rather than relying on how it's described inside the 2007 paper — before citing its own sample size and design independently.
Alongside StemEnhance®, Prime Time+ includes Alomac®, a newer ingredient derived from Aloe macroclada — a rare aloe species found only in Madagascar, distinct from the common Aloe vera used elsewhere in the category — studied for cellular resilience, epithelial barrier integrity, and tissue maintenance signaling through a route that's mechanistically distinct from StemEnhance®'s. CyanthOx™, a polyphenol-dense sea buckthorn extract sourced from the Tibetan Plateau, supports the vascular and endothelial environment those mobilized cells travel through and, ultimately, repair. And astaxanthin's unique membrane-spanning structure — with polar end groups anchored on both sides of the lipid bilayer — provides antioxidant protection across the full thickness of the cell membrane, protecting that same tissue environment from oxidative damage.
Pathway 03: Mitochondrial and Metabolic Resilience
Two actives target the formula's third pillar. Alpha-ketoglutarate (AKG) is a Krebs cycle intermediate and a co-substrate for more than 70 human enzymes, including the TET enzymes and Jumonji-domain demethylases that regulate DNA methylation and histone modification — giving it a direct, if still-emerging, connection to epigenetic aging markers alongside its established role in mitochondrial energy production, amino acid synthesis, and mTOR regulation. AKG has one of the more interesting evidence trails of any ingredient in this formula. In mice, a calcium-AKG formulation extended lifespan and compressed late-life morbidity relative to untreated controls (Asadi Shahmirzadi et al., Cell Metabolism, 2020) — a well-cited finding, though translating a mouse lifespan result to a human outcome is never automatic. In humans, the most-cited data point is a small, uncontrolled pilot analysis of 42 adults taking a calcium-AKG formulation (as the branded product Rejuvant®) for an average of seven months, which reported an average 8-year reduction in DNA-methylation-based biological age (Demidenko et al., Aging, 2021). That result is genuinely striking, but the authors themselves are explicit about its limits: there was no placebo control, the analysis was retrospective on existing customers, and they call for randomized trials before it should be treated as confirmed — a caveat worth repeating here rather than leaving out. A placebo-controlled human trial (the ABLE study) has since been designed specifically to address that gap, with results not yet published as of this writing. CyaninPlus®, a concentrated phycocyanin extract from blue spirulina, is one of the more potent natural COX-2 pathway modulators identified in plant biology, with anti-inflammatory activity mediated structurally through its tetrapyrrole chromophore's ability to scavenge peroxyl radicals.
The Foundation: Making Sure the Formula Actually Absorbs
A formula's ingredient list matters less if the body struggles to use what's in it. Prime Time+ includes AstraGin® — a combined extract of Astragalus membranaceus and Panax notoginseng — at 50 mg, studied for its potential to support upregulation of intestinal nutrient transporter proteins; one of its active compounds, astragaloside IV, has also been studied for a possible role in stem cell proliferation signaling, giving it a secondary connection to the second pathway above. Ioniplex®, a fulvic ionic mineral complex at 100 mg, is included for its studied role in supporting cellular mineral transport and mitochondrial efficiency. Neither ingredient carries its own headline claim in this formula — both are included to help support the three pathways above, not to independently guarantee greater absorption on their own.
Where This Fits in a Practitioner's Protocol
Prime Time+ was designed as a daily foundational formula for practitioners building comprehensive healthy-aging protocols — particularly when cellular quality control, mitochondrial resilience, regenerative signaling, and nutrient utilization are priorities for a given patient. It's intended as a nutraceutical layer that complements individualized, lab-informed protocol design, not a substitute for it.
Prime Time+ is available now. See the full label, dosing, and formula for the complete ingredient panel and specifications.
References
1. Pekar T, Bönisch F, Wirthgen E, et al. The positive effect of spermidine in older adults suffering from dementia: First results of a 3-month trial. Wiener klinische Wochenschrift. 2021;133(11-12):484–491.
2. Wirth M, Schwarz C, Benson G, et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Network Open. 2022;5(6):e2213875.
3. Hofer SJ, Simon AK, Bergmann M, Eisenberg T, Kroemer G, Madeo F. Spermidine is essential for fasting-mediated autophagy and longevity. Nature Cell Biology. 2024;26(9):1571–1584.
4. POLYCAD trial protocol. A randomised, double-blind, placebo-controlled trial of spermidine supplementation in elderly patients with coronary artery disease. Trials. 2025. ClinicalTrials.gov identifier: NCT06186102 (protocol published; results not yet available).
5. Jensen GS, Hart AN, Zaske LA, et al. Mobilization of human CD34+CD133+ and CD34+CD133− stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae. Cardiovascular Revascularization Medicine. 2007;8(3):189–202.
6. Asadi Shahmirzadi A, Edgar D, Liao CY, et al. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice. Cell Metabolism. 2020;32(3):447–456.
7. Demidenko O, Barardo D, Budovsky A, et al. Rejuvant®, a potential life-extending compound formulated with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test. Aging. 2021;13(22):24485–24499.
Full reference details available on request.